GlassScriptPhysician profile
Stephen B Chiang
NPI 1386634269
$3,184.78
in general payments reported to CMS, 2019-2025
12 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $282 · 2021: $323 · 2022: $196 · 2023: $1,020 · 2024: $881 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,067 · Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,066.64 |
| Food and Beverage | $1,003.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $871.39 | 2020-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Intuitive Surgical, INC. | $680.09 | 2023 | Da Vinci Surgical System |
| Axonics, INC. | $569.55 | 2024 | Axonics, Bulkamid |
| Siemens Medical Solutions USA, INC. | $365.92 | 2019-2024 | Biograph Vision 600 (8 Ring/64 Ct) |
| Ge Healthcare | $254.59 | 2019-2022 | |
| Davol INC. | $139.66 | 2023 | Arista Ah Flexitip |
| Sirtex Medical INC | $135.19 | 2020 | |
| Novartis Pharmaceuticals Corporation | $75.40 | 2021 | |
| Telix Pharmaceuticals | $32.50 | 2025 | Illuccix |
| Bayer Healthcare Pharmaceuticals INC. | $22.65 | 2025 | |
| Blue Earth Diagnostics | $19.31 | 2023 | |
| Biocompatibles, INC. | $18.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Chiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.